Literature DB >> 1942116

Spleen function in children with sickle B+ thalassemia.

N J Barrios1, D V Kirkpatrick, D Lohman, C C McMullen, W Wilson, J R Humbert.   

Abstract

Splenic function in patients with sickle B+ (SB+) thalassemia has been poorly documented. We evaluated the clinical course and splenic function in 12 children with SB+ thalassemia with simultaneous technetium sulfur colloid spleen scans and determination of pitted erythrocytes by direct interference contrast microscopy (DICM). All patients displayed normal uptake of radiocolloid. Mean percentage of pitted erythrocytes was 2.2% compared to 0.06% in 10 normal eusplenic controls and 13.8% in 10 sickle cell patients. In this group of children, who were carefully monitored for 136 patient years, there was no episode of bacteremia/sepsis, and a low prevalence of vaso-occlusive episodes. The slight increase in percentage of pitted erythrocytes of SB+ thalassemia patients does not seem to herald any clinically relevant loss of splenic function. SB+ thalassemia children younger than 10 years of age who do not seem to present a higher risk of invasive bacterial infections than eusplenic children, should receive conservative treatment for isolated febrile episodes and should not be submitted to prophylactic penicillin.

Entities:  

Mesh:

Year:  1991        PMID: 1942116      PMCID: PMC2627097     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  5 in total

1.  Discrepancy between pit counting and spleen function tests in nutritional anemias and hemoglobinopathy C.

Authors:  M A Zago; F F Costa; D T Covas; M S Figueiredo; C Bottura
Journal:  Nouv Rev Fr Hematol       Date:  1986

2.  Functional asplenia in sickle-cell anemia.

Authors:  H A Pearson; R P Spencer; E A Cornelius
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

3.  Developmental aspects of splenic function in sickle cell diseases.

Authors:  H A Pearson; S McIntosh; A K Ritchey; J S Lobel; Y Rooks; D Johnston
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

4.  Clinicopathologic characteristics of septicemia in sickle cell disease.

Authors:  J S Lobel; K E Bove
Journal:  Am J Dis Child       Date:  1982-06

5.  Developmental pattern of splenic dysfunction in sickle cell disorders.

Authors:  H A Pearson; D Gallagher; R Chilcote; E Sullivan; J Wilimas; M Espeland; A K Ritchey
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

  5 in total
  1 in total

1.  Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia.

Authors:  Jeffrey D Lebensburger; Rakeshkumar J Patel; Prasannalaxmi Palabindela; Christina J Bemrich-Stolz; Thomas H Howard; Lee M Hilliard
Journal:  J Blood Med       Date:  2015-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.